Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 JTE-061 cream in plaque psoriasis
jRCT2031210253Phase 3Completed
- Sponsor
- Japan Tobacco
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tapinarof in plaque psoriasis (3 arms), sponsored by Japan Tobacco. Primary endpoint: PGA responder rate at Week 12. Started Oct 2021; status: completed.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2031210253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210253.